» Articles » PMID: 2070345

Biological Safety Cabinetry

Overview
Specialty Microbiology
Date 1991 Apr 1
PMID 2070345
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The biological safety cabinet is the one piece of laboratory and pharmacy equipment that provides protection for personnel, the product, and the environment. Through the history of laboratory-acquired infections from the earliest published case to the emergence of hepatitis B and AIDS, the need for health care worker protection is described. A brief description with design, construction, function, and production capabilities is provided for class I and class III safety cabinets. The development of the high-efficiency particulate air filter provided the impetus for clean room technology, from which evolved the class II laminar flow biological safety cabinet. The clean room concept was advanced when the horizontal airflow clean bench was manufactured; it became popular in pharmacies for preparing intravenous solutions because the product was protected. However, as with infectious microorganisms and laboratory workers, individual sensitization to antibiotics and the advent of hazardous antineoplastic agents changed the thinking of pharmacists and nurses, and they began to use the class II safety cabinet to prevent adverse personnel reactions to the drugs. How the class II safety cabinet became the mainstay in laboratories and pharmacies is described, and insight is provided into the formulation of National Sanitation Foundation standard number 49 and its revisions. The working operations of a class II cabinet are described, as are the variations of the four types with regard to design, function, air velocity profiles, and the use of toxins. The main certification procedures are explained, with examples of improper or incorrect certifications. The required levels of containment for microorganisms are given. Instructions for decontaminating the class II biological safety cabinet of infectious agents are provided; unfortunately, there is no method for decontaminating the cabinet of antineoplastic agents.

Citing Articles

Approach of design for air mass balance in an aseptic processing area for cell-based products.

Furomitsu S, Mizutani M, Kino-Oka M Regen Ther. 2024; 28:20-29.

PMID: 39664364 PMC: 11629579. DOI: 10.1016/j.reth.2024.11.009.


The Role of the Biosafety Cabinet in Preventing Infection in the Clinical Laboratory.

Jagtap G, Badge A, Kohale M, Wankhade R Cureus. 2024; 15(12):e51309.

PMID: 38288229 PMC: 10823295. DOI: 10.7759/cureus.51309.


Total astragalosides decrease apoptosis and pyroptosis by inhibiting enterovirus 71 replication in gastric epithelial cells.

Zhang X, Hao J, Sun C, Du J, Han Q, Li Q Exp Ther Med. 2022; 23(3):237.

PMID: 35222714 PMC: 8815049. DOI: 10.3892/etm.2022.11162.


Biologically-Based and Physiochemical Life Support and In Situ Resource Utilization for Exploration of the Solar System-Reviewing the Current State and Defining Future Development Needs.

Keller R, Porter W, Goli K, Rosenthal R, Butler N, Jones J Life (Basel). 2021; 11(8).

PMID: 34440588 PMC: 8398003. DOI: 10.3390/life11080844.


Assessment of knowledge of oral pathologists and postgraduate students on safe laboratory practices during the COVID-19 pandemic.

Nishat R, Babu N, Srinivas Murthy S, Deepak V, Mukherjee S, Sundar Behura S J Oral Maxillofac Pathol. 2021; 24(3):437-445.

PMID: 33967477 PMC: 8083421. DOI: 10.4103/jomfp.jomfp_442_20.


References
1.
AVIS K, Levchuk J . Special considerations in the use of vertical laminar-flow workbenches. Am J Hosp Pharm. 1984; 41(1):81-7. View

2.
Reid D . Incidence of tuberculosis among workers in medical laboratories. Br Med J. 1957; 2(5035):10-4. PMC: 1961649. DOI: 10.1136/bmj.2.5035.10. View

3.
FALCK K, Grohn P, Sorsa M, Vainio H, Heinonen E, HOLSTI L . Mutagenicity in urine of nurses handling cytostatic drugs. Lancet. 1979; 1(8128):1250-1. DOI: 10.1016/s0140-6736(79)91939-1. View

4.
SILANTEV E, ANKUDINOV V, KOLESOV S . [on anthrax immunity following the effect on the body of ionizing radiations]. Zh Mikrobiol Epidemiol Immunobiol. 1962; 33:121-3. View

5.
Sieber S, Adamson R . Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res. 1975; 22:57-155. DOI: 10.1016/s0065-230x(08)60176-1. View